CERO THERAPEUTICS HOLDINGS, INC. Payments for Repurchase of Convertible Preferred Stock
CERO THERAPEUTICS HOLDINGS, INC. (CERO) had Payments for Repurchase of Convertible Preferred Stock of $750.00 thousand as of 2026-03-06, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock · last filed 2026-08-14
- 2026-03-06: Payments for Repurchase of Convertible Preferred Stock $750.00K.
| Period end | Payments for Repurchase of Convertible Preferred Stock |
|---|---|
| 2026-03-06 | $750.00K 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |